Seliciclib的封面
书籍主题:

Seliciclib

Cyclin-Dependent Kinase

Part Press (2011-09-28 )

Books loader

Omni badge 有获得代金券的资格
ISBN-13:

978-613-8-59837-4

ISBN-10:
6138598377
EAN:
9786138598374
书籍语言:
英文
作品简介:
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. R-roscovitine (Seliciclib or CYC202) is a trial drug in the family of pharmacological cyclin-dependent kinase (CDK) inhibitors that preferentially inhibit multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase or state within the cell cycle of treated cells. Seliciclib is being developed by Cyclacel. Seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex infection, and the mechanisms of chronic inflammation disorders. Seliciclib is a 2,6,9-substituted purine analog. Its structure in complex with CDK2 was determined in 1996. Seliciclib inhibits CDK2/E, CDK2/A, CDK7 and CDK9.
出版社 :
Part Press
网址:
http://www.betascript-publishing.com
出版发行由:
Ben Stacy Jerrik
页码 :
148
发表日期:
2011-09-28
现货:
备有现货
类别:
化学
价格:
45.00 €
关键词:
drug, Kinase, dependent, trial, Pharmacological, Cyclin

Books loader

时事通讯

Adyen::diners Adyen::jcb Adyen::discover Adyen::amex Adyen::mc Adyen::visa Adyen::cup Adyen::unionpay Adyen::paypal Paypal CryptoWallet 银行转帐

LOGIN
  0产品在购物车内
编辑购物车
Loading frontend
LOADING